ANTH
ANTHERA PHARMS INC NEW by Anthera Pharmaceuticals, Inc. (ANTH)
$00
About ANTHERA PHARMS INC NEW by Anthera Pharmaceuticals, Inc. (ANTH)
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Houston, TX.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
2,600
Dividend yield
0.00%
Volume
--
Avg. volume
3,322
P/E ratio
--
ANTHERA PHARMS INC NEW by Anthera Pharmaceuticals, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
2,600
Dividend yield
0.00%
Volume
--
Avg. volume
3,322
P/E ratio
--